1.Predominant endotype of nasal polyps in a sample of Filipinos following endoscopic sinus surgery for chronic rhinosinusitis with nasal polyposis
Karla Victoria Nable-Llanes ; Rodante A. Roldan
Philippine Journal of Otolaryngology Head and Neck Surgery 2021;36(1):28-32
Objective:
To determine the prevalence of eosinophilic and non-eosinophilic nasal polyps in Filipino patients with chronic rhinosinusitis with nasal polyposis (CRSwNP) who underwent endoscopic sinus surgery.
Methods:
Design: Retrospective Chart Review.
Setting: Tertiary Government Training Hospital.
Participants: A consecutive sample of adult patients who underwent endoscopic sinus surgery for chronic rhinosinusitis with nasal polyposis at the Rizal Medical Center from 2015-2019.
Results:
Out of 66 patients who underwent endoscopic sinus surgery during the study period, 36 (54.55%) had an eosinophilic endotype while 30 (45.45%) had a non-eosinophilic endotype.
Conclusion
The slight predominance of eosinophilic nasal polyps found in our sample may suggest a contrasting trend compared to our Asian neighbors, who have a predominantly non[1]eosinophilic endotype – Indonesia (90.47%), Thailand (81.9%), South Korea (66.7%) and China (53.6%). However, this predominance is still lower than the 78-88% eosinophilia reported among Caucasians. Larger series may confirm these preliminary findings
Chronic rhinosinusitis
;
Paranasal Sinuses
;
Sinusitis
;
Nasal Polyps
2.Decreased FEF 50 as an indicator of comorbid asthma and persistent airflow limitation in patients with chronic rhinosinusitis with nasal polyps: A cross-sectional study.
Xuechen WANG ; Fangyuan LI ; Chengshuo WANG ; Kai HUANG ; Shen SHEN ; Ming WANG ; Jianmin JIN ; Luo ZHANG
Chinese Medical Journal 2024;137(3):353-355
3.Socioeconomic Status Impacts the Prognosis of Chronic Rhinosinusitis Treated by Endoscopic Sinus Surgery: An Observational Cohort Study in Northeast China.
Shuai HAO ; Xue Yan ZHANG ; Jiao GAO ; Yan WANG ; Ai Hui YAN
Biomedical and Environmental Sciences 2023;36(11):1059-1067
OBJECTIVE:
To explore the association between socioeconomic status (SES) and postoperative outcomes in patients with chronic sinusitis (CRS) after functional endoscopic sinus surgery (ESS).
METHODS:
We conducted an observational cohort study of 1,047 patients with CRS undergoing ESS. Discharged patients were followed up to 72 weeks for all-cause recurrence events. Baseline SES was established based on occupation, education level, and family income of the patients 1 year before the operation. Kaplan-Meier method was used to calculate the recovery rate after ESS, and Cox proportional hazards regression analysis was used to evaluate the relationship between SES and prognosis.
RESULTS:
Patients of middle SES had lower unadjusted all-cause recurrence than those of low or high SES; 24-week overall recovery rate was 90.4% [95 % confidence interval ( CI): 89.6%-91.2%] in patients of middle SES, 13.5% (95 % CI: 12.8%-14.2%) in patients of low SES, and 31.7% (95 % CI: 30.7%-32.7%) in patients of high SES (both log-rank P < 0.001). After adjustment for covariates, hazard ratios ( HRs) were 7.69 (95 % CI: 6.17-9.71, P trend < 0.001) for all-cause recurrence for low SES versus middle SES, and 6.19 (95 % CI: 4.78-7.93, P trend < 0.001) for middle SES versus high SES.
CONCLUSION
Low SES and high SES were more associated with the worse prognosis of CRS patients after ESS than middle SES.
Humans
;
Cohort Studies
;
Rhinosinusitis
;
Sinusitis/surgery*
;
Social Class
;
Endoscopy/methods*
;
Chronic Disease
;
Treatment Outcome
4.Artificial intelligence-assisted prediction of olfactory disorders in patients with chronic rhinosinusitis.
Jingyuan CHEN ; Wenyi CHEN ; Xin LUO ; Xuekun HUANG ; Yana ZHANG ; Qintai YANG
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2023;37(11):871-885
Objective:To analyze the influencing factors and perform the prediction of olfactory disorders in patients with chronic rhinosinusitis(CRS) based on artificial intelligence. Methods:The data of 75 patients with CRS who underwent nasal endoscopic surgery from October 2021 to February 2023 in the Department of Otorhinolaryngology Head and Neck Surgery, the Third Affiliated Hospital of Sun Yat-sen University were analyzed retrospectively. There were 53 males and 22 females enrolled in the study, with a median age of 42.0 years old. The CRS intelligent microscope interpretation system was used to calculate the proportion of area glands and blood vessels occupy in the pathological sections of each patient, and the absolute value and proportion of eosinophils, lymphocytes, plasma cells and neutrophils. The patients were grouped according to the results of the Sniffin' Sticks smell test, and the clinical baseline data, differences in nasal mucosal histopathological characteristics, laboratory test indicators and sinus CT were compared between the groups. Determine the independent influencing factors of olfactory disorders and receiver operating characteristic curves(ROC) were used to evaluate the performance of the prediction model. Statistical analysis was performed using SPSS 25.0 software. Results:Among the 75 CRS patients, 25 cases(33.3%) had normal olfaction and 50 cases(66.7%) had olfactory disorders. Multivariate Logistic regression analysis showed that tissue eosinophils percentage(OR=1.032, 95%CI 1.002-1.064, P=0.036), Questionnaire of olfactory disorders-Negative statement(QOD-NS)(OR=1.079, 95%CI 1.004-1.160, P=0.040) and Anterior olfactory cleft score(AOCS)(OR=2.672, 95%CI 1.480-4.827, P=0.001) were independent risk factors for olfactory disorders in CRS patients. Further research found that the area under the ROC curve(AUC) of the combined prediction model established by the tissue eosinophil percentage, QOD-NS and AOCS was 0.836(95%CI 0.748-0.924, P<0.001), which is better than the above single factor prediction model in predicting olfactory disorders in CRS. Conclusion:Based on pathological artificial intelligence, tissue eosinophil percentage, QOD-NS and AOCS are independent risk factors for olfactory disorders in CRS patients, and the combination of the three factors has a good predictive effect on CRS olfactory disorders.
Male
;
Female
;
Humans
;
Adult
;
Retrospective Studies
;
Artificial Intelligence
;
Rhinosinusitis
;
Rhinitis/complications*
;
Nasal Polyps/complications*
;
Sinusitis/complications*
;
Olfaction Disorders/etiology*
;
Smell
;
Chronic Disease
5.The expression and significance of Piezo1 in chronic rhinosinusitis with nasal polyps.
Longlan SHU ; Yijun LIU ; Panhui XIONG ; Xiaocong JIANG ; Bowen ZHENG ; Yu GU ; Yang SHEN ; Yucheng YANG
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2023;37(11):886-896
Objective:To explore the expression and importance of Piezo1, E-cadherin, and Vimentin in nasal polyps patients. Methods:Thirty-five patients undergoing endoscopic sinus surgery under general anesthesia were streamed into 20 cases of nasal polyps(NP group) and 15 cases of simple septoplasty without any sinus disease(Control group). Immunofluorescence staining and Western Blot were applied to detect the protein level of Piezo1, E-cadherin, and Vimentin in NP tissues and nasal polyp-derived primary human nasal epithelial cells(pHNECs). Also, BEAS-2B cell lines were treated with human TGF-β1 protein to establish epithelial mesenchymal transition(EMT) model in vitro and quantitative real-time polymerase chain reaction were used to calculate Piezo1 and above biomarkers in the model. Results:Compared with control group, Piezo1 and Vimentin showed higher level while E-cadherin was lower in NP tissues and pHNECs.In EMT model in vitro, Piezo1 and Vimentin were demonstrated higher expression with decreased level of E-cadherin. Conclusion:The tendency of Piezo1 is consistent with the mesenchymal-related biomarker Vimentin, going against with epithelial-related biomarker E-cadherin, implying its involvement with EMT process in nasal polyps.
Humans
;
Biomarkers/metabolism*
;
Cadherins/metabolism*
;
Chronic Disease
;
Epithelial-Mesenchymal Transition
;
Nasal Polyps/metabolism*
;
Rhinosinusitis
;
Sinusitis
;
Transforming Growth Factor beta1/metabolism*
;
Vimentin/metabolism*